Joint statement Association for Accessible Medicines – Medicines for Europe ahead of 5th EU-U.S. Trade and Technology Council Ministerial meeting
26 January 2024
Medicines for Europe and its members are strongly concerned by the first judgement on the Supplementary Protection Certificate (SPC) manufacturing waiver issued by the Munich District Court, Germany in October 2023.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
